Yale Spinout, Osmol, Gets Approval to Initiate First-in-Human Phase 1 Clinical Trial of OSM-0205 for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)
Yale Engineering Dean's Invited Speaker Series: C.C Wei '85, CEO, TSMC and Gina Raimondo '98, U.S. Secretary of Commerce 10/02/2023 3:30PM—4:30PM
Genovac Enters Exclusive Licensing Agreement with Pfizer and Yale for Therapeutic Antibody Candidates
Yale Engineering Dean's Invited Speaker Series: Kathryn Guarini '94, CIO at IBM 09/27/2023 3:00PM—4:00PM
Yale Engineering Dean's Invited Speaker Series: Bratin Saha, VP, Machine Learning Services, Amazon AI 10/09/2023 3:00PM—4:00PM